Enhanced immune response in porcine species
US11439703B2 · kind B2 · utility
0Cited by
9References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 28, 2016 |
| Grant date | Sep 13, 2022 |
| Priority date | — |
| Expiry date | Dec 17, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/55561
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention generally relates to methods of eliciting an immune response in a porcine species subject. In particular, an immunomodulator composition is used to induce an immune response to enhance the subject's ability to fight infectious pathogens.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.